Upstate Active Clinical Trials
Study Title:Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients.
What is the purpose of the study?Randomized treatment study to look at effects of combination chemotherapy with or without rituximab in treating younger patients with stage III or stage IV non-Hodgkin lymphoma or B-cell acute leukemia.
Upstate Institutional Review Board (IRB) Number:361624
Patient Age Group:Children
Principal Investigator:Karol H Kerr, MD
Who can I contact for more information?
Name: Beatriz Kovar